Skip to main content

Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and circulating ACE levels are not associated with outcome in septic critically ill patients


Several studies of critically ill patients have suggested an association of the D/D genotype of the insertion/deletion (I/D) angiotensin-converting enzyme (ACE) polymorphism with poor outcome probably by enhancing the inflammatory response and leading to a procoagulant state. Our aim was to evaluate the effect of both the ACE I/D polymorphism and its gene product, on the clinical outcome of critically ill septic patients.


The study cohort included 186 consecutive Caucasian patients with sepsis, severe sepsis or septic shock. Epidemiological, clinical data and co-morbidities along with severity scores were recorded. Measurements of serum ACE activity and genotyping for ACE I/D polymorphism were carried out in all patients. The primary outcomes were the 28-day and 90-day mortalities; secondary outcomes included the number of days without renal or cardiovascular failure, and ventilation-free days over the 28-day period following the study enrollment. One hundred and eighty healthy blood donors were genotyped and used as controls.


The genotype distribution in the patients' group was comparable with that observed in controls (P = 0.45). ACE I/D polymorphism and circulating ACE levels were not associated with mortality (P > 0.05) or with secondary outcomes including ventilation-free days and days without cardiovascular or renal failure among septic critically ill patients (P > 0.05). See Figure 1.

Figure 1
figure 1

Kaplan-Meier curves of survival up to 28 days for the three ACE gene polymorphisms.


Neither the ACE I/D polymorphism nor the serum ACE levels seem to be significant prognostic factors of the outcome of sepsis in critically ill patients.

Author information

Authors and Affiliations


Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Tsangaris, I., Tsantes, A., Kopterides, P. et al. Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and circulating ACE levels are not associated with outcome in septic critically ill patients. Crit Care 15 (Suppl 1), P282 (2011).

Download citation

  • Published:

  • DOI:


  • Septic Shock
  • Secondary Outcome
  • Severe Sepsis
  • Septic Patient
  • Significant Prognostic Factor